Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1290.369
  • -16.069-1.23%
Trading Dec 27 12:26 ET
1307.237High1288.694Low
Constituent Stocks: 10Top Rising: SGMO-0.57%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
SGMOSangamo Therapeutics
2.615-0.015-0.57%1.93M5.03M2.6202.6302.7302.530545.61M533.56M208.65M204.04M+13.20%+36.91%+13.70%+220.27%+647.14%+381.32%+381.32%--0.95%LossLoss7.61%Biotechnology
AAgilent Technologies
135.035-0.795-0.59%131.74K17.85M134.590135.830136.222134.59038.57B38.42B285.60M284.52M+1.39%-4.17%-2.25%-7.85%+7.84%-2.38%-2.38%0.70%0.05%30.4830.481.20%Diagnostics & Research
APLSApellis Pharmaceuticals
32.760-0.195-0.59%209.66K6.88M32.86032.95533.33032.4404.08B2.76B124.39M84.36M-1.15%+0.06%-4.04%+15.03%-12.73%-45.27%-45.27%--0.25%LossLoss2.70%Biotechnology
VRTXVertex Pharmaceuticals
405.280-5.370-1.31%527.64K215.01M405.260410.650410.980404.490104.37B104.07B257.53M256.79M+2.18%-12.68%-12.76%-12.30%-16.61%-0.40%-0.40%--0.21%Loss29.181.58%Biotechnology
BLUEbluebird bio
8.650-0.130-1.48%135.52K1.20M8.6708.7809.1408.60084.10M83.70M9.72M9.68M-6.28%+13.82%+14.48%-11.23%-56.75%-68.66%-68.66%--1.40%LossLoss6.15%Biotechnology
CRSPCRISPR Therapeutics
40.080-0.990-2.41%875.49K35.34M40.75041.07041.14039.8703.42B3.36B85.35M83.95M-0.76%-11.72%-21.16%-12.32%-27.17%-35.97%-35.97%--1.04%LossLoss3.09%Biotechnology
EDITEditas Medicine
1.195-0.035-2.85%1.59M1.95M1.2301.2301.3401.18098.64M92.40M82.55M77.32M-10.82%-36.77%-45.68%-62.89%-75.66%-88.20%-88.20%--2.06%LossLoss13.00%Biotechnology
NTLAIntellia Therapeutics
11.768-0.352-2.90%1.01M12.00M11.99012.12012.30011.6901.20B1.18B101.85M100.57M-2.58%-13.21%-22.63%-36.56%-47.13%-61.40%-61.40%--1.00%LossLoss5.03%Biotechnology
CRBUCaribou Biosciences
1.615-0.085-5.00%538.37K887.99K1.6901.7001.7451.610146.24M131.75M90.55M81.58M-10.77%-16.75%-26.59%-9.27%-0.31%-71.82%-71.82%--0.66%LossLoss7.94%Biotechnology
BEAMBeam Therapeutics
26.800-1.900-6.62%252.81K6.99M28.57028.70028.74526.8002.22B1.84B82.81M68.58M-0.19%-4.49%-1.47%+14.04%+12.42%-1.54%-1.54%--0.37%LossLoss6.78%Biotechnology

Comments

Read more